AE-3763 is primarily utilized in the field of medicinal chemistry and pharmaceutical research, particularly for the treatment of neurological and brain-related diseases such as Alzheimer's and Parkinson's disease. It demonstrates potential in improving neuronal cell function and reducing inflammation in the brain. Furthermore, its efficacy is studied in inhibiting specific enzymes involved in the pathological processes of these diseases, positioning it as a promising compound for future drug development. Its applications extend to preclinical studies evaluating pharmacokinetics, safety profile, and mechanism of action, and it may serve as a reference compound in developing new chemical entities, advancing drug discovery and understanding of disease mechanisms.